You are here

  • Home
  • Archive
  • Volume 17, Issue 2
  • Intensive statin therapy, compared with moderate dose, increases risk of new onset diabetes but decreases risk of cardiovascular events

Article info

Article menu
Download PDFPDF
Therapeutics
Systematic review and meta-analysis
Intensive statin therapy, compared with moderate dose, increases risk of new onset diabetes but decreases risk of cardiovascular events

Authors

  1. Correspondence to Swapnil N Rajpathak
    US Outcomes Research, Merck, 351 N Sumneytown Pike, UG2MW-05, North Wales, PA 19454, USA; swapnil.rajpathak{at}merck.com
View Full Text

Citation

Rajpathak SN
Intensive statin therapy, compared with moderate dose, increases risk of new onset diabetes but decreases risk of cardiovascular events
BMJ Evidence-Based Medicine 2012;17:55-56.

Publication history

  • First published September 26, 2011.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions